The treatment of neonatal jaundice Progress.docVIP

 PAGE \* MERGEFORMAT 15 The treatment of neonatal jaundice Progress [Abstract] Neonatal jaundice is a common phenomenon in the neonatal period. In this paper, the last two years the treatment of neonatal jaundice reported in the literature were summarized and analyzed to explore the new progress of neonatal jaundice, neonatal jaundice to show cause, and re-understanding of the extent the latest results. for the treatment of neonatal jaundice and prevention of bilirubin brain injury is significant. [Keywords:] neonatal jaundice; hemoglobin; serum bilirubin; bilirubin encephalopathy; treatment Neonatal jaundice is due to immaturity of neonatal bilirubin metabolism, blood bilirubin increased, the skin appears yellowish discoloration of mucous membrane of the phenomenon. Neonatal jaundice is a common phenomenon in the neonatal period, 60 children and 80% of the term % of preterm children can be 2 to 3 days after birth, jaundice, jaundice, and patients were divided into physiological jaundice, if not cure, bilirubin may be deposited on the formation of bilirubin encephalopathy in the brain, ranging from leaving the nervous system serious complications, while in leading neonatal deaths. Research in recent years with the deepening of neonatal jaundice, resulting in many new treatments, now nearly three years of its latest treatment advances are summarized below. 1 Western medicine Li Lixin [1] The treatment of neonatal Smecta effect of breast milk jaundice, and luminal and traditional medicines - could Lamine comparison. 60 cases of full term normal weight, exclusive breastfeeding, moderate risk of breast milk jaundice children were randomly divided into treatment group and smecta luminal - can lamin treatment group comparisons of the efficacy and impact on breastfeeding, and detection and treatment of breast milk before and after the baby fecal β-glucuronidase enzyme activity concentration, the treatment of Smecta mechanisms of breast milk jaundice. sm